體外診斷電子商務商業模式的增長機會
市場調查報告書
商品編碼
1109313

體外診斷電子商務商業模式的增長機會

In Vitro Diagnostic eCommerce Business Models Growth Opportunities

出版日期: | 出版商: Frost & Sullivan | 英文 73 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

COVID-19 加速了醫療保健的數字化,包括體外診斷 (IVD)。技術創新還為診斷領域的新電子商務平台解決方案提供了機會,重點是全球連通性、透明度、訪問、可擴展性和成本效率。

本報告檢查和分析全球體外診斷中的電子商務業務模式,提供有關戰略要務、增長機會、競爭格局和各種用例的信息。

內容

戰略要務

增長機會分析

  • 調查目的和調查方法
  • 體外診斷電子商務行業形勢
  • 市場細分
  • 增長驅動力
  • 抑制增長的因素

體外診斷電子商務商業模式從宏觀到微觀

  • 從宏觀到微觀的願景
  • 患者、提供者和醫生對技術的採用
  • 跨行業合作讓行業參與者能夠探索潛在的合作機會
  • 行業互聯互通是 B2B 和 B2C 市場力量的倍增器

供應鏈參與者和使用情況

  • 優先渠道和戰略重點
  • 首選通道:按診斷設備類型
  • 首選渠道:按解決方案服務類型
  • 市場吸引力和合作機會

體外診斷中的 B2B/B2B2C 電子商務 - 競爭格局、供需問題、策略和用例

  • IVD 和電子商務市場的競爭環境
  • B2B 電子商務供需渠道問題
  • 體外診斷電子商務行業參與者的策略
  • B2B 供應鏈市場對分銷價值鏈投資者的好處
  • 用例 - Abbott Diagnostics
  • 用例 - Siemens Healthineers
  • 用例 - Thermo Fisher Scientific Corporation
  • 用例 - LabX
  • 用例 - KWIPPED

研發供應和使用案例

  • 研發供應鏈-在線平台承諾市場機會
  • 用例 - ZAGENO, Inc.
  • 用例 - Science.com
  • 用例 - Wazoku

B2C 的數字/電子藥房 - 競爭格局、問題、策略和用例

  • B2C 數字/電子藥店的競爭環境
  • 數字/電子藥房公司的 B2C 問題
  • B2C 數字/電子藥房行業參與者的戰略
  • 面向 B2C 的數字/電子藥房提供以客戶為中心的增值服務和產品
  • 使用案例 - 亞馬遜藥房
  • 用例 - CVS 藥房
  • 案例研究 - Walgreens Boots Alliance
  • 結論

增長機會宇宙

  • 增長機會 1 - 技術支持的電子商務供應鏈可提供可擴展的客戶體驗
  • 增長機會 2 - 研發電子商務市場為研究人員和科學家開闢了機會,優化了成本和時間
  • 增長機會 3 - 用於綜合疾病管理的遠程藥房服務

附錄

  • 電子商務與電子商務的區別
  • 商業模式的轉變
  • 展品清單
  • 免責聲明
簡介目錄
Product Code: K789-55

Disruptive Differentiation in Supply Chain Management Drives New Growth Potential

Diagnostics are central to healthcare, but not accessible to all. A 2020 Lancet study states that 47% of the global population has little to no access to accurate diagnostics, emphasizing the need for equitable distribution across geographies and containing procurement costs. The COVID-19 pandemic increased demand for personal protective equipment, consumables for molecular diagnostics, vaccines, and POCT testing for SARS-Cov2. However, serious glitches in supply and logistics due to poor procurement strategies led to manufacturing delays and a surge in diagnostics and healthcare costs. Vendors of R&D prototyping, small-batch manufacturing services, and niche testing labs recorded the largest revenue drop across the value chain. The coronavirus also accelerated healthcare digitalization, including in vitro diagnostics (IVD).

Engineering and technological innovations present opportunities to create new eCommerce platform solutions in the diagnostics segment, emphasizing global connectivity, transparency, access, scalability, and cost efficiencies. These features reduce the gaps in the IVD industry, improve access, and democratize diagnostics to empower providers, payers, and patients. Lessons learned from the pandemic in 2020 and 2021 serve as the building blocks to strengthen healthcare systems, primarily timely health service delivery, attention to the healthcare workforce, need for robust health information systems, access to diagnostics (analogous to essential medicines), efficient supply chain for procurement and supplies, and seamless communication and interconnectedness, financing, leadership, and governance. eCommerce marketplaces for healthcare and IVD provide an opportunity to buy, sell, lease, market, and procure diagnostic products and service information on any internet device, such as the computer (web-based) or mobile (mCommerce). Pharmaceuticals, biotech companies, contract research organizations, hospitals, clinics, universities, laboratories, government, and customers can use these technology platforms to access the global ecosystem. While technology infrastructure within eCommerce is evolving, essential technologies enabling healthcare transactions include EDI, bar codes, cloud, product data exchange, and electronic forms. This study assesses the eCommerce business potential across sectors, creating resilient healthcare and diagnostic market opportunities for R&D, manufacturing, and supply chain functions. It explores other scalable, cost-efficient business opportunities with new B2B products, customized outsourcing services, and technology-enabled tools for efficiency and ease of operations. The IVD market is buoyant due to the soaring demand for products, molecular diagnostics, immunoassays, and POCT in chronic diseases. The rise in consumerization, telehealth, and ePharmacy also push it toward further digitalization with advanced artificial intelligence, machine learning, and the internet of things technologies. The study also examines the competitive environment, strategies, market models, and use cases for success in the IVD eCommerce platform industry.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the In Vitro Diagnostic eCommerce Platform Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Research Objective and Methodology
  • In Vitro Diagnostic Ecommerce Industry Landscape
  • Market Segmentation
  • Growth Drivers
  • Growth Drivers (continued)
  • Growth Restraints
  • Growth Restraints (continued)

Macro to Micro In Vitro Diagnostic eCommerce Business Model

  • Macro to Micro Visioning
  • Technology Adoption Among Patients, Providers, and Physicians
  • Cross-sector Collaborations Encourage Industry Players to Explore Potential Partnership Opportunities
  • Cross-sectoral Interconnectedness Acts as a Force Multiplier for B2B and B2C Markets

Supply Chain Participants and Use

  • Preferred Channels and Strategic Priorities
  • Preferred Channels and Strategic Priorities (continued)
  • Preferred Channels and Strategic Priorities (continued)
  • Preferred Channel by Diagnostic Device Type
  • Preferred Channel by Solutions and Service Types
  • Market Attractiveness and Partnership Opportunity

IVD B2B, B2B2C eCommerce-Competitive Environment, Supply-Demand Pain Points, Strategies, and Use Cases

  • Competitive Environment-IVD and eCommerce Marketplace
  • Competitive Environment-IVD and eCommerce Marketplace (continued)
  • B2B eCommerce Supply and Demand Channel Pain Points
  • Strategies of IVD eCommerce Industry Participants
  • Strategies of IVD eCommerce Industry Participants (continued)
  • Strategies of IVD eCommerce Industry Participants (continued)
  • Strategies of IVD eCommerce Industry Participants (continued)
  • Strategies of IVD eCommerce Industry Participants (continued)
  • B2B Supply Chain Marketplace Benefits for Distribution Value Chain Stakeholders
  • Use Case-Abbott Diagnostics
  • Use Case-Siemens Healthineers
  • Use Case-Thermo Fisher Scientific Corporation
  • Use Case-LabX
  • Use Case-KWIPPED

R&D Supply and Use Cases

  • R&D Supply Chain-Online Platform Promises Market Opportunities
  • Use Case-ZAGENO, Inc.
  • Use Case-Science.com
  • Use Case-Wazoku

B2C Digital/ePharmacyUse Case-WazokuCompetitive Environment, Pain Points, Strategies, and Use Cases

  • Competitive Environment-B2C Digital/ePharmacy
  • Pain Points of B2C Digital/ePharmacy Providers and Suppliers
  • Strategies of B2C Digital/ePharmacy Industry Participants
  • Strategies of IVD B2C Digital/ePharmacy Industry Participants (continued)
  • B2C Digital/ePharmacy Offers Customer-centric Value-added Services and Products
  • Use Case-Amazon Pharmacy
  • Use Case-CVS Pharmacy
  • Case Study-Walgreens Boots Alliance
  • Conclusion

Growth Opportunity Universe

  • Growth Opportunity 1-Technology-enabled eCommerce Supply Chain for Scalability Enhanced Customer Experience
  • Growth Opportunity 1-Technology-enabled eCommerce Supply Chain for Scalability and Enhanced Customer Experience (continued)
  • Growth Opportunity 2-R&D eCommerce Marketplace Opens Opportunities and Optimizes Cost and Time for Researchers and Scientists
  • Growth Opportunity 2-R&D eCommerce Marketplace Opens Opportunities and Optimizes Cost and Time for Researchers and Scientists (continued)
  • Growth Opportunity 3-Telepharmacy Services for Comprehensive Disease Management
  • Growth Opportunity 3-Telepharmacy Services for Comprehensive Disease Management (continued)

Appendix

  • The Difference Between eCommerce and eBusiness
  • Business Model Shift
  • Business Model Shift (continued)
  • List of Exhibits
  • Legal Disclaimer